Press Releases
GT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023
GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
GT Biopharma Names Charles J. Casamento to the Board of Directors
GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
GT Biopharma Issues Open Letter to Shareholders Detailing Recent Activities
GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering Priced At Premium To Market
GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022
